ArticlePloS one2017

Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritis.

Naoki Iwamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.